IPO over-allotment exercise
Company: CoreWeave
The claim, verbatim
In April 2025 underwriters partially exercised their over-allotment option, buying an additional 2 million Class A shares at the IPO price for net proceeds of $68 million.
Source (primary)
CoreWeave 10-Q filed 2026-11-12 (SEC EDGAR, sec_filing)
View cached copy (2026-11-13)Live source ↗
Quote: “In April 2025, the underwriters exercised a portion of their over-allotment option and purchased from the Company an additional 2 million shares of Class A common stock at the IPO price, which resulted in net proceeds to the Company of $ 68 million”
How we checked this
Checked on November 14, 2026. The cited source supports every part of this claim.
The filing states that in April 2025 the underwriters partially exercised their over-allotment option, buying 2 million more Class A shares at the IPO price for $68 million in net proceeds.
Confirmed in the source:
- In April 2025 the underwriters exercised part of their over-allotment option
- The underwriters bought an additional 2 million Class A shares
- The shares were bought at the IPO price
- Net proceeds to CoreWeave were $68 million
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1769628/000176962826000465/crwv-20260930.htm) in full (520,426 characters, retrieved November 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms CoreWeave 10-Q filed 2026-11-12
Quote: “In April 2025, the underwriters exercised a portion of their over-allotment option and purchased from the Company an additional 2 million shares of Class A common stock at the IPO price, which resulted in net proceeds to the Company of $ 68 million”